The natural interferon-alpha producing cells in systemic lupus erythematosus (Q35024789)

5 August 2017

1 reference

title

The natural interferon-alpha producing cells in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

5 August 2017

main subject

0 references

author name string

Lars Rönnblom

series ordinal

1

1 reference

5 August 2017

Gunnar V Alm

series ordinal

2

1 reference

5 August 2017

publication date

1 December 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

63

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

1181-1193

1 reference

Virus interference. I. The interferon

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The molecular cell biology of interferon-gamma and its receptor

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The human interferon alpha species and receptors

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interferon-gamma: biology and role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Innate immune responses to LCMV infections: natural killer cells and cytokines

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Initial and innate responses to viral infections--pattern setting in immunity or disease

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interferons alpha and beta as immune regulators--a new look

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Cytokines as a link between innate and adaptive antitumor immunity.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The function of type I interferons in antimicrobial immunity.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Role of interferons and other cytokines in the regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interferon-producing cells: on the front line in immune responses against pathogens

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Dendritic cell lineage, plasticity and cross-regulation

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Therapeutic advances in the management of hepatitis B and hepatitis C.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interferon in the management of neuroendocrine GEP-tumors: a review

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Auto-immune thrombocytopenia related to interferon therapy

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Immune-mediated complications during interferon therapy in hematological patients

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Dendritic cells in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Type I interferons and the Th1/Th2 paradigm

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

IFN-alpha/beta enhances BCR-dependent B cell responses

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Potent and selective stimulation of memory-phenotype CD8 T cells in vivo by IL-15.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Clinical relevance of autoantibodies in systemic rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Serum interferon levels in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Possible involvement of interferon alfa in the pathogenesis of fever in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Properties of human natural interferon-producing cells stimulated by tumor cell lines

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Human natural interferon-alpha producing cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The cell surface phenotype of human natural interferon-alpha producing cells as determined by flow cytometry

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The nature of the principal type 1 interferon-producing cells in human blood

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Stimulation of natural interferon-alpha/beta-producing cells by Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Herpes simplex virus induces appearance of interferon-alpha/beta-producing cells and partially interferon-alpha/beta-dependent accumulation of leukocytes in murine regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interferon-alpha production and tissue localization of interferon-alpha/beta producing cells after intradermal administration of Aujeszky's disease virus-infected cells in pigs

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Etiopathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Inflammation in autoimmunity: receptors for IgG revisited

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Fcgamma receptors in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The induction of interferon-alpha and interferon-beta mRNA in human natural interferon-producing blood leukocytes requires de novo protein synthesis

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Interferons and the Colony-Stimulating Factors IL-3 and GM-CSF Enhance the IFN-alpha Response in Human Blood Leucocytes Induced by Herpes Simplex Virus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Whence interferon? Variety in the production of interferon in response to viral infection.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

On the role of IRF in host defense

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Reciprocal control of T helper cell and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

An etiopathogenic role for the type I IFN system in SLE.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Danger signals: SOS to the immune system

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Natural adjuvants: endogenous activators of dendritic cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

The type I interferon system is locally activated in psoriatic lesions.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Gene expression profiling in DQA1*0501 children with untreated dermatomyositis: a novel model of pathogenesis

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: a candidate therapeutic for IDDM and SLE

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Prolonged allograft survival in cynomolgus monkeys treated with a monoclonal antibody to the human type I interferon receptor and low doses of cyclosporine

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1016/S0198-8859(02)00757-7

7 January 2021

10.1016/S0198-8859(02)00757-7

Identifiers

DOI

1 reference

5 August 2017

1 reference